China · What does LYZZ Capital invest in?
LYZZ Capital invests most often at Series A (100% of the rounds on record), in sectors such as Healthcare, Biotech and Pharmaceuticals.
LYZZ Capital highlights
- 01
1 rounds on record
- 02
Mostly Series A: 100% of its rounds
What they do
LYZZ Capital is a leading global healthcare-dedicated VC/PE firm.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- HealthcareBiotechPharmaceuticals
- Based in
- Shanghai, China
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2018
1 round
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
6 of 19 we have independently watched raise
Alpha BiopharmaMojia BiotechNeurelisNewMed MedicalOnchilles PharmaQpex BiopharmaBeianChipscreenHanYu MedicalHongyu MedicalJumpcode GenomicsLidakang TechnologyMabworks BiotechMicroTech MedicalQingyun TechnologyRongsheng MedicalSino BiopharmaYuanmoZenshine
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.